Evidence map›Paper›PMID 29651702›Full record

ArticleHepatology international2018

Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation.

Tetsuyuki Takahashi, Ulrich Deuschle, Shu Taira, Takeshi Nishida, Makoto Fujimoto, Takao Hijikata, Koichi Tsuneyama

Abstract read
PubMed Publisher
In one paragraph

Article in Hepatology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Dysregulation of serum bile acids in liver cancer: a systematic review and meta-analysis.Metabolomics : Official journal of the Metabolomic Society · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Tetsuyuki TakahashiDepartment of Anatomy and Cell Biology, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, 202-8585, Japan.
Ulrich DeuschlePhenex Pharmaceuticals AG, 69123, Heidelberg, Germany.
Shu TairaDepartment of Bioscience, Fukui Prefectural University, Fukui, 910-1195, Japan.
Takeshi NishidaDepartment of Diagnostic Pathology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.
Makoto FujimotoDepartment of Japanese Oriental Medicine, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.
Takao HijikataDepartment of Anatomy and Cell Biology, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, 202-8585, Japan.
Koichi TsuneyamaDepartment of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, 770-8503, Japan. tsuneyama.koichi@tokushima-u.ac.jp.ORCID http://orcid.org/0000-0002-0670-9868
Musashino University · JPUniversity of Toyama · JPFukui Prefectural University · JPPhenex Pharmaceuticals (Germany) · DETokushima University · JP

Funding

JSPS KAKENHI JP15K06783JSPS KAKENHI JP15K15098
6 · The paper itself

Abstract

BACKGROUND AND

aimsTsumura-Suzuki obese diabetic (TSOD) is a good model of metabolic syndrome showing typical lesions found in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, and develops spontaneous hepatic tumors with a high frequency. Majority of the developing tumors overexpress glutamine synthetase (GS), which is used as a marker of hepatocellular carcinoma (HCC). The aim of this study is to assess the status of expression of metabolism-related genes and the level of bile acids in the TSOD mice-derived tumors and to determine the association with metabolic dysregulation between human HCC and TSOD mice-derived tumors.

methodsGS-positive hepatic tumors or adjacent normal tissues from 71-week-old male TSOD mice were subjected to immunohistochemical staining, quantitative RT-PCR (qRT-PCR), quantitation of cholic acid and taurocholic acid.

resultsWe found that downregulation of the rate-limiting enzyme for betaine synthesis (BADH), at both mRNA and protein levels in GS-positive TSOD mice-derived tumors. Furthermore, the bile acid receptor FXR and the bile acid excretion pump BSEP (Abcb11) were found to be downregulated, whereas BAAT and Akr1c14, involved in primary bile acid synthesis and bile acid conjugation, were found to be upregulated at mRNA level in GS-positive TSOD mice-derived tumors. BAAT and Akr1c14 were also overexpressed at protein levels. Total cholic acid was found to be increased in GS-positive TSOD mice-derived tumors.

conclusionOur results strongly support the significance of TSOD mice as a model of spontaneously developing HCC.

Indexed as

AcyltransferasesAldehyde ReductaseAnimalsATP Binding Cassette Transporter, Subfamily B, Member 11Betaine-Aldehyde DehydrogenaseCarcinoma, HepatocellularCholic AcidDiabetes Mellitus, ExperimentalDisease Models, AnimalDown-RegulationGene ExpressionGlutamate-Ammonia LigaseHumansLiver NeoplasmsMaleMiceAbcb11 protein, mouseAcyltransferasesAldehyde Reductasealdo-keto reductase family 1, member C14 protein, mouseATP Binding Cassette Transporter, Subfamily B, Member 11Betaine-Aldehyde Dehydrogenasebile acid-CoA amino acid N-acyltransferaseCholic AcidGlutamate-Ammonia LigaseReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearRNA, MessengerTaurocholic AcidBile acidHCCSpontaneous tumorigenesis modelTSOD miceTumor metabolism

Identifiers

PMID29651702
OpenAlexW2798071039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.